Showing 403 results

Filters Content type: News, Editors' picks Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Changing treatment

Biktarvy combo maintains viral suppression after switching therapy

News
7 March 2018
Changing treatment

Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

News
13 February 2018
HIV treatment

Boosted protease inhibitor and lamivudine provides effective maintenance treatment

News
26 October 2017
Changing treatment

HIV Regimen Switch May Contribute to Weight Gain

Editor's pick
Monthly Prescribing Reference
9 October 2017
New & experimental HIV treatments

Maraviroc matches boosted protease inhibitor treatment over 96 weeks

News
11 September 2017
Generic medicines

No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds

News
24 August 2017
Changing treatment

Terrence Higgins Trust and BHIVA advise on the use of generic HIV antiretroviral therapy

Editor's pick
Terrence Higgins Trust
16 August 2017
Changing treatment

Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

News
9 August 2017
Changing treatment

HIV: A therapeutic advance for resource-limited settings

Editor's pick
Eurekalert Inf Dis
31 May 2017
Neurological & cognitive problems

Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study

News
10 May 2017
Access to healthcare

A quarter of people with second-line ART treatment failure in Kenya have exhausted current treatment options

News
25 April 2017
Generic medicines

Switching from Atripla to generic-containing regimens can produce large cost savings

News
23 April 2017
New & experimental HIV treatments

Bone density improves in people who switch from tenofovir DF to tenofovir alafenamide

News
27 March 2017
New & experimental HIV treatments

Dolutegravir monotherapy fails to maintain HIV viral suppression, but dolutegravir + lamivudine looks good

News
9 March 2017
Treatment simplification strategies

Dual antiretroviral regimen maintains durable HIV suppression after switch

News
15 February 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
Resistance

High prevalence of resistance to zidovudine among people in sub-Saharan Africa experiencing virological failure with tenofovir-containing ART

News
15 December 2016
Changing treatment

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

News
10 November 2016
Treatment simplification strategies

Darunavir/ritonavir & lamivudine matches triple-drug therapy

News
31 October 2016
Changing treatment

Two-drug HIV therapy just as effective as three-drug therapy

News
25 October 2016
Side effects

Doctors in Netherlands observe higher than expected dolutegravir treatment discontinuation rate

News
13 October 2016
Viral load

Spanish study gives reassurance: small HIV blips do not predict treatment failure

News
21 September 2016
Changing treatment

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Editor's pick
BETA blog
20 September 2016
Changing treatment

Most people taking second-line ART in sub-Saharan Africa achieve viral suppression but there's a need for third-line treatment options

News
12 August 2016